Microbiology Lecture: Antibiotics, Leprosy, and Microbiota

History of Antibiotics and Chemotherapy

• Definition of antibiotics: chemicals used to treat disease; broad definition includes antibiotics for bacterial infections and other diseases treated with chemicals.
• Key concept in chemotherapy: the drug must be more toxic to the bacteria than to the host (pathogen-targeted toxicity).
• 1910: Paul Ehrlich and Salvarsan
  • Ehrlich tested many arsenical compounds; Salvarsan (arsphenamine), often referred to as the “606” compound, was among the first treatments that worked well for bacterial infections, notably syphilis, which was prevalent in the early 1900s.
• 1928: Alexander Fleming and penicillin
  • Fleming discovered penicillin, the first true antibiotic.
  • Definition reminder: an antibiotic is a substance produced naturally by another organism (typically a fungus or bacterium).
  • Penicillin takes its name from the Penicillium fungus; natural production is key to defining an antibiotic.
• Antibiotics today include natural products and derivatives
  • Many antibiotics used clinically are derivatives produced in labs.
• Why do fungi/bacteria produce antibiotics?
  • Primary purpose is to protect themselves and prevent competition for limited resources; if you can kill a competitor, you gain more access to nutrients.
• Fleming’s discovery: a classic ‘happy accident’
  • Staphylococcus aureus culture left on a bench; mold contamination produced a chemical inhibitory effect, visible as a zone of inhibition near the mold, indicating antibacterial compounds.
• Impact of penicillin in the 1940s
  • Penicillin production during World War II saved thousands of lives by treating bacterial infections, allowing more soldiers to recover and return to fighting.
• The big problem: antibiotic resistance
  • Resistance to penicillin appeared about $10$ years after introduction, illustrating a persistent challenge in clinical microbiology.
  • Resistance remains a major issue; strategies exist to mitigate resistance, but it is a fundamental property of bacteria–antibiotic interactions.
• Related fields in microbiology (contextual overview)
  • Mycology: study of fungi.
  • Parasitology: study of parasites.
  • Immunology: the immune response to microbes; foundational overlap with microbiology.
  • Virology: study of viruses; a relatively newer field compared to bacteria.
  • Recombinant DNA technology: uses microbes for biotechnology; e.g., inserting human genes into bacteria to produce proteins.
• Recombinant DNA technology example and significance
  • Human insulin gene inserted into Escherichia coli; bacteria express insulin; rapid growth allows massive production of insulin, surpassing older methods (e.g., using animal sources).
• Closing thought on history
  • The history of antibiotics intertwines discovery, biology, medicine, and public health; it continues to shape modern therapeutics and microbial management.

Leprosy (Hansen’s Disease)

• Historical context and evidence
  • Leprosy appears in skeletal remains dating back to around $2000 ext{ BCE}$.
  • The Bible references leprosy and lepers, though the term historically encompassed a range of skin conditions beyond true leprosy.
  • Cultural stigma: lepers were often shunned, a social consequence complicating historical understanding.
• Nomenclature
  • The disease is commonly called leprosy or Hansen’s disease.
  • The term “leprosy” derives from the Greek word for scaly; lighter-skin lesions can appear scaly.
• Key clinical feature
  • Nerve damage is the hallmark; the bacteria preferentially colonize cooler parts of the body.
  • Affected sites include digits (fingers and toes) and the nose; trunk involvement is less common due to body temperature.
• Global burden and geography
  • Worldwide incidence: roughly $2\times 10^5$ new cases per year; concentrated in warmer, tropical regions; the United States reports very few cases, with some in the Southern states such as Texas.
• Disease forms
  • Tuberculoid (milder form): few skin lesions; nerve involvement; hair follicles and sweat glands in affected areas can be destroyed.
  • Lepromatous/Lepromatosis (more severe form): numerous skin lesions across the body; nasal collapse can occur (lion-like appearance); progressive muscle wasting (atrophy); potential eye involvement leading to blindness; vocal cords may be affected, causing a whisper-like voice; death can occur, usually from secondary infections rather than direct bacterial kill.
• Causative agents
  • Two bacteria from the genus Mycobacterium can cause leprosy: Mycobacterium leprae and Mycobacterium lepromatosis.
  • Both are acid-fast and Gram-positive; the genus is characterized by mycolic acids in their cell walls.
• Culturing challenges
  • Mycobacterium leprae/lepraem: notoriously slow-growing and difficult to culture in standard laboratory media.
  • Historically, labs have used specialized approaches such as armadillo models or nude mice to propagate the bacteria for study.
  • Armadillos are natural reservoirs in some regions (e.g., the Southern US), which explains localized human cases.
• Transmission and incubation
  • Transmission requires prolonged close contact; droplet spread is possible but not highly efficient.
  • Incubation period is uncertain, estimated between $9 ext{ months}$ and $20 ext{ months}$, a very wide range.
  • Approximately 5 ext{%} of exposed individuals develop disease; most exposed do not, which helps explain the historical scarcity of contagious spread.
• Reservoirs and exposure routes
  • Armadillos serve as animal reservoirs; human-to-human transmission generally requires sustained contact.
  • Lab animals (e.g., nude mice) and armadillos are used in research due to culture challenges.
• Treatment: multidrug therapy (MDT)
  • MDT typically uses a combination of at least three antibiotics; common agents include rifampicin and minocycline (and others in different regimens).
  • Duration can be lengthy: on the short end, several months; on the long end, up to $24 ext{ months}$.
  • Adherence challenges are prominent, especially in resource-limited settings where diagnosis, access to ongoing care, and drug supply can be limited.
  • Global distribution of cases remains influenced by healthcare access, logistics, and antibiotic availability.
• Public health and exam context
  • Disease-of-the-day topics are used as supplements; quizzes cover modules in the textbook, while disease topics inform exam content.
  • Study guides for leprosy emphasize key facts: cause (Mycobacterium spp.), main symptoms (nerve damage, skin lesions), forms (tuberculoid vs lepromatous), transmission (limited, prolonged contact), treatment (MBT/MDT, long duration), and reservoir aspects (armadillos in some regions).

Infection, Disease, and Normal Microbiota

• Definitions and distinctions
  • Infection: colonization of the body by a microorganism; the pathogen takes up residence.
  • Disease: a state in which infection leads to symptoms and impaired function; a change from health to illness.
  • It is possible to have infection without disease (e.g., incubation period, or silent colonization).
  • Example: HIV infection can occur for years before AIDS develops; many pathogens cause infection without immediate disease.
  • Often used terminology: infection vs disease; also the shift from STD to STI reflects the presence of infection without overt disease.
• Normal microbiota vs transient microbiota
  • Normal microbiota (normal flora): microbes that normally reside in or on the body and provide beneficial functions; should be in their usual sites.
  • Numbers: human body hosts roughly between $10^{13}$ and $10^{14}$ human cells and roughly between $10^{13}$ and $10^{14}$ microbial cells (numbers are close to 1:1 per the referenced material).
  • Common sites: mouth, gut, skin, nose, reproductive tract; each site hosts characteristic communities.
  • Roles of normal microbiota:
  • Gut microbiota synthesize and provide Vitamin K, which is essential for blood clotting; without it, risks of brain hemorrhages from leaks would increase.
  • Residents aid digestion and nutrient breakdown (e.g., E. coli in the gut helps with digestion in healthy individuals).
  • Normal microbiota protect against infection by occupying niches and resources (competitive exclusion).
  • Transient microbiota: organisms transiently present in a location; they may be opportunistic pathogens if placed in the right (or wrong) context.
  • Issues when normal microbiota are disrupted: antibiotics can wipe out protective flora, allowing pathogens to cause disease (e.g., Clostridioides difficile infections in the gut; yeast infections in the female reproductive tract).
• Competitive exclusion and the “king of the hill” concept
  • In the gut, dense, stable communities prevent overgrowth by newcomers; removing this barrier (e.g., via antibiotics) can allow pathogens like C. difficile to proliferate.
  • Reintroduction or restoration of normal flora can mitigate pathogenic overgrowth.
• Antibiotics and disruptions
  • Antibiotic usage is a major disruptor of microbiota balance and can predispose to infections like yeast infections and C. difficile.
• The Human Microbiome Project (HMP)
  • Initiated around $2007$ to catalog and compare microbial communities across humans worldwide.
  • Goal: understand how microbiota composition correlates with health, disease risk, and various conditions.
  • Conceptual shift: microbiome science emerged as a foundational aspect of human health, linking microbial communities to disease risk and physiological function.
• Practical implications and connections
  • The microbiome concept informs drug development, probiotic therapies, and personalized medicine.
  • Microbiota research highlights the importance of maintaining balanced communities for health and disease prevention.

Module Four: HIV/AIDS and Pathophysiology (Overview)

• Historical emergence and identification
  • In the 1980s, clinicians observed unusual infections and cancers in patients in LA and New York, prompting epidemiological inquiry.
  • Through symptom progression and epidemiology, researchers identified HIV as the causative agent of AIDS, marking a watershed moment in infectious disease understanding.
• Infection vs disease in the context of HIV/AIDS
  • Infections can precede disease; HIV can be present for years before AIDS-defining illnesses develop.
  • Understanding the host immune status is crucial for determining progression from HIV infection to AIDS.
• Terminology and framing
  • The shift from terminology such as sexually transmitted disease (STD) to sexually transmitted infection (STI) reflects recognition that infection can occur without disease.
  • This nuance influences public health messaging and clinical practice.

Miscellaneous Concepts and Exam Preparation Tips

• Pathogen-host relationships and screening
  • Infections can exist without symptoms; many pathogens have incubation periods with variable onset times.
• Study strategies for disease-of-the-day topics
  • Focus on causative agents, major symptoms, transmission routes, reservoirs, and treatment strategies.
  • Expect matching-type questions that require you to pair diseases with key characteristics.

Quick Reference: Key Numbers and Terms

• Incubation period for leprosy: $9 ext{ months} \le \text{incubation} \le 20 ext{ months}$
• Global annual leprosy cases: $2\times 10^5$
• Time to resistance emergence after penicillin: approximately $10\text{ years}$
• Multidrug therapy (MDT) for leprosy: at least three antibiotics; common components include rifampicin and minocycline; duration ranges from months to up to $24 ext{ months}$
• Normal human vs microbial cell counts: approximately $10^{13}$–$10^{14}$ human cells and $10^{13}$–$10^{14}$ microbial cells
• Microbial agents mentioned: Mycobacterium leprae, Mycobacterium lepromatosis; acid-fast, Gram-positive; genus Mycobacterium
• Reservoirs: armadillos (in some regions), nude mice (research models)
• Notable historical milestones: Salvarsan (606) for syphilis; penicillin discovery by Fleming; penicillin’s impact on WWII mortality